320
Participants
Start Date
June 28, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
DCSZ11
A monoclonal antibody that binds to CD93, DCSZ11 will be administered as a single intravenous (IV) infusion on Day 1 in each 21-day cycle.
Pembrolizumab
Pembrolizumab injection
Doxorubicin
1b SOC Cohort 1: Doxorubicin combination in soft tissue sarcoma
Tebentafusp
1b SOC Cohort 2: Tebentafusp combination in uveal melanoma
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
Kaohsiung Medical University Chung-ho Memorial Hospital, Kaohsiung City
RECRUITING
St Vincent's Hospital, Sydney
RECRUITING
Scientia Clinical Research, Randwick
COMPLETED
Cabrini Hospital, Malvern
RECRUITING
Monash Health, Clayton
WITHDRAWN
University of Sunshine Coast, Buderim
RECRUITING
The Queen Elizabeth Hospital (TQEH), Woodville South
RECRUITING
Southern Oncology Clinical Research Unit (SOCRU), Bedford Park
RECRUITING
Linear Clinical Research Limited, Nedlands
RECRUITING
MonteFiore, The Bronx
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
Cha University Bundang Medical Center, Gyeonggi-do
RECRUITING
John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
RECRUITING
Mayo Clinic, Jacksonville
RECRUITING
University of Miami, Miami
RECRUITING
University of Alabama, Birmingham
RECRUITING
SCRI Oncology Partners, Nashville
RECRUITING
Ohio State University, Columbus
RECRUITING
Inje University Haeundae Paik Hospital, Busan
RECRUITING
Dong-a University Hospital, Busan
RECRUITING
Mayo Clinic, Rochester
RECRUITING
University of Colorado, Aurora
RECRUITING
Sarah Cannon Research Institute Denver Healthone, Denver
RECRUITING
Mayo Clinic, Phoenix
RECRUITING
HonorHealth, Scottsdale
RECRUITING
Yale Cancer Center, New Haven
COMPLETED
Dana Farber Cancer Institute, Boston
RECRUITING
Townsville Hospital, Douglas
COMPLETED
Liverpool Hospital, Liverpool
RECRUITING
Mater Misericordiae Health Services Brisbane Ltd, South Brisbane
WITHDRAWN
Sydney Adventist Hospital, Wahroonga
WITHDRAWN
Asan Medical Center, Seoul
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
Lead Sponsor
DynamiCure Biotechnology
INDUSTRY